154 related articles for article (PubMed ID: 29356965)
21. Evasion of Innate Immunity Contributes to Small Cell Lung Cancer Progression and Metastasis.
Zhu M; Huang Y; Bender ME; Girard L; Kollipara R; Eglenen-Polat B; Naito Y; Savage TK; Huffman KE; Koyama S; Kumanogoh A; Minna JD; Johnson JE; Akbay EA
Cancer Res; 2021 Apr; 81(7):1813-1826. PubMed ID: 33495232
[TBL] [Abstract][Full Text] [Related]
22. Immune surveillance in glioblastoma: Role of the NKG2D system and novel cell-based therapeutic approaches.
Chitadze G; Kabelitz D
Scand J Immunol; 2022 Aug; 96(2):e13201. PubMed ID: 35778892
[TBL] [Abstract][Full Text] [Related]
23. Impairment of NKG2D-Mediated Tumor Immunity by TGF-β.
Lazarova M; Steinle A
Front Immunol; 2019; 10():2689. PubMed ID: 31803194
[TBL] [Abstract][Full Text] [Related]
24. Molecular signature of stem-like glioma cells (SLGCs) from human glioblastoma and gliosarcoma.
Zechel C; Loy M; Wegner C; Dahlke E; Soetje B; Baehr L; Leppert J; Ostermaier JJ; Lueg T; Nielsen J; Elßner J; Willeke V; Marzahl S; Tronnier V; Madany Mamlouk A
PLoS One; 2024; 19(2):e0291368. PubMed ID: 38306361
[TBL] [Abstract][Full Text] [Related]
25. NOS2 expression in glioma cell lines and glioma primary cell cultures: correlation with neurosphere generation and SOX-2 expression.
Palumbo P; Miconi G; Cinque B; Lombardi F; La Torre C; Dehcordi SR; Galzio R; Cimini A; Giordano A; Cifone MG
Oncotarget; 2017 Apr; 8(15):25582-25598. PubMed ID: 28424427
[TBL] [Abstract][Full Text] [Related]
26. Recruiting T cells and sensitizing tumors to NKG2D immune surveillance for robust antitumor immune response.
Li X; Guo X; Huang J; Lin Q; Qin B; Jiang M; Shan X; Luo Z; Zhang J; Shi Y; Lu Y; Liu X; Du Y; Yang F; Luo L; You J
J Control Release; 2023 Jan; 353():943-955. PubMed ID: 36535542
[TBL] [Abstract][Full Text] [Related]
27. Poly-guanidine shows high cytotoxicity in glioma cell cultures and glioma stem cells.
Márquez M; Olausson KH; Alaiya A; Nilsson S; Meurling L; Holmberg AR
Invest New Drugs; 2022 Jun; 40(3):565-575. PubMed ID: 35312943
[TBL] [Abstract][Full Text] [Related]
28. MMP-2 Inhibitor-Mediated Tumor Microenvironment Regulation Using a Sequentially Released Bio-Nanosystem for Enhanced Cancer Photo-Immunotherapy.
Liu H; Lei D; Li J; Xin J; Zhang L; Fu L; Wang J; Zeng W; Yao C; Zhang Z; Wang S
ACS Appl Mater Interfaces; 2022 Sep; 14(37):41834-41850. PubMed ID: 36073504
[TBL] [Abstract][Full Text] [Related]
29. Lipid Peroxidation Plays an Important Role in Chemotherapeutic Effects of Temozolomide and the Development of Therapy Resistance in Human Glioblastoma.
Wu W; Wu Y; Mayer K; von Rosenstiel C; Schecker J; Baur S; Würstle S; Liesche-Starnecker F; Gempt J; Schlegel J
Transl Oncol; 2020 Mar; 13(3):100748. PubMed ID: 32087559
[TBL] [Abstract][Full Text] [Related]
30. Role of NKG2D and its ligands in cancer immunotherapy.
Liu H; Wang S; Xin J; Wang J; Yao C; Zhang Z
Am J Cancer Res; 2019; 9(10):2064-2078. PubMed ID: 31720075
[TBL] [Abstract][Full Text] [Related]
31. The Role and Regulation of the NKG2D/NKG2D Ligand System in Cancer.
Tan G; Spillane KM; Maher J
Biology (Basel); 2023 Aug; 12(8):. PubMed ID: 37626965
[TBL] [Abstract][Full Text] [Related]
32. Targeting glioma-initiating cells via the tyrosine metabolic pathway.
Yamashita D; Bernstock JD; Elsayed G; Sadahiro H; Mohyeldin A; Chagoya G; Ilyas A; Mooney J; Estevez-Ordonez D; Yamaguchi S; Flanary VL; Hackney JR; Bhat KP; Kornblum HI; Zamboni N; Kim SH; Chiocca EA; Nakano I
J Neurosurg; 2020 Feb; 134(3):721-732. PubMed ID: 32059178
[TBL] [Abstract][Full Text] [Related]
33. The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma Models.
Gravina GL; Mancini A; Colapietro A; Delle Monache S; Sferra R; Vitale F; Cristiano L; Martellucci S; Marampon F; Mattei V; Beirinckx F; Pujuguet P; Saniere L; Lorenzon G; van der Aar E; Festuccia C
Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30871240
[TBL] [Abstract][Full Text] [Related]
34. CX3CR1 and malignant progression of glioma.
Lee S; Deneen B; Rao G
Aging (Albany NY); 2021 Sep; 13(17):20856-20857. PubMed ID: 34516407
[No Abstract] [Full Text] [Related]
35. Soluble NKG2D ligands impair CD8
Zhang Y; Luo F; Dong K
Oncol Lett; 2023 Jul; 26(1):297. PubMed ID: 37274476
[TBL] [Abstract][Full Text] [Related]
36. c-Myc Targets HDAC3 to Suppress NKG2DL Expression and Innate Immune Response in N-Type SCLC through Histone Deacetylation.
Zhao P; Sun X; Li H; Liu Y; Cui Y; Tian L; Cheng Y
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158730
[TBL] [Abstract][Full Text] [Related]
37.
Huang L; Wang Z; Chang Y; Wang K; Kang X; Huang R; Zhang Y; Chen J; Zeng F; Wu F; Zhao Z; Li G; Huang H; Jiang T; Hu H
Aging (Albany NY); 2020 May; 12(9):8397-8412. PubMed ID: 32396873
[TBL] [Abstract][Full Text] [Related]
38. Convergent Evolution by Cancer and Viruses in Evading the NKG2D Immune Response.
Baugh R; Khalique H; Seymour LW
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33352921
[TBL] [Abstract][Full Text] [Related]
39. Slow Off-Rate Modified Aptamer (SOMAmer) Proteomic Analysis of Patient-Derived Malignant Glioma Identifies Distinct Cellular Proteomes.
Thanasupawat T; Glogowska A; Pascoe C; Krishnan SN; Munir M; Begum F; Beiko J; Krcek J; Del Bigio MR; Pitz M; Shen Y; Spicer V; Coombs KM; Wilkins J; Hombach-Klonisch S; Klonisch T
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502484
[TBL] [Abstract][Full Text] [Related]
40. Stem cell-assisted enzyme/prodrug therapy makes drug-resistant ovarian cancer cells vulnerable to natural killer cells through upregulation of NKG2D ligands.
Li G; Nikkhoi SK; Hatefi A
Med Oncol; 2023 Mar; 40(4):110. PubMed ID: 36862260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
